Literature DB >> 12065695

Nonsteroidal anti-inflammatory drugs induce apoptosis in association with activation of peroxisome proliferator-activated receptor gamma in rheumatoid synovial cells.

Ryuta Yamazaki1, Natsuko Kusunoki, Takeshi Matsuzaki, Shusuke Hashimoto, Shinichi Kawai.   

Abstract

Nonsteroidal anti-inflammatory drugs (NSAIDs) have been reported to induce apoptosis in a variety of cell lines. In this study, we examined the effect of NSAIDs on the growth and apoptosis of synovial cells from patients with rheumatoid arthritis and analyzed the activation of peroxisome proliferator-activated receptor gamma (PPARgamma) as a possible mechanism of action of NSAIDs. Cell proliferation and viability were assessed from 5-bromo-2'-deoxyuridine incorporation and by 4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene disulfonate (WST-1) assay, respectively. The apoptosis of synovial cells was identified by DNA fragmentation assay and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling assay. Indometacin, diclofenac, oxaprozin, and zaltoprofen reduced cell proliferation and induced apoptotic cell death in synovial cells, whereas ketoprofen and acetaminophen did not. N-[2-(cyclohexyloxyl)-4-nitrophenyl]-methanesulfonamide (NS-398), a selective cyclooxygenase-2 inhibitor, also inhibited cell proliferation, whereas it did not cause apoptosis. Rheumatoid synovial cells expressed PPARgamma mRNA, and the PPARgamma ligands 15-deoxy-Delta(12,14)-prostaglandin J(2) and troglitazone reduced the proliferation and induced apoptosis in synovial cells. Luciferase reporter assay demonstrated that not only PPARgamma ligands but also NSAIDs, which could induce apoptosis, increased the activation of PPARgamma in synovial cells. Furthermore, the ability of NSAIDs and PPARgamma ligands to stimulate the activation of PPARgamma correlated with their ability to decrease cell viability(r = 0.92, p < 0.01) and ability to induce DNA fragmentation (r = 0.97, p < 0.001) in synovial cells. These results suggest that PPARgamma is an attractive target for induction of apoptosis in rheumatoid synovial cells and that the activation of the PPARgamma pathway is associated with the apoptotic action of NSAIDs.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12065695     DOI: 10.1124/jpet.302.1.18

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  The use of Cox-2 and PPARγ signaling in anti-cancer therapies.

Authors:  Lucia Knopfová; Jan Smarda
Journal:  Exp Ther Med       Date:  2010-03-01       Impact factor: 2.447

2.  Analysis of two sequence variants in peroxisome proliferator activated receptor gamma gene in Tajik population at high altitudes and Han population at low altitudes in China.

Authors:  Xiao-Ling Liu; Feng-Lin Zhang; Zhi-Yong Zhou; Hua-Lu Zhao; Guo-Min Shen; Wu-Yun Baohan; Zi-Yuan Duan; Wei Li; Jun-Wu Zhang
Journal:  Mol Biol Rep       Date:  2009-06-23       Impact factor: 2.316

3.  Delayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: role of the Akt/IkappaB kinase/nuclear factor kappaB pathway.

Authors:  Luciano Ottonello; Maria Bertolotto; Fabrizio Montecucco; Giordano Bianchi; Franco Dallegri
Journal:  Br J Pharmacol       Date:  2009-03-26       Impact factor: 8.739

4.  Induction but not inhibition of COX-2 confers human lung cancer cell apoptosis by celecoxib.

Authors:  Robert Ramer; Udo Walther; Philipp Borchert; Stefan Laufer; Michael Linnebacher; Burkhard Hinz
Journal:  J Lipid Res       Date:  2013-08-12       Impact factor: 5.922

5.  Host targeted activity of pyrazinamide in Mycobacterium tuberculosis infection.

Authors:  Claudia Manca; Mi-Sun Koo; Blas Peixoto; Dorothy Fallows; Gilla Kaplan; Selvakumar Subbian
Journal:  PLoS One       Date:  2013-08-28       Impact factor: 3.240

6.  Anti-tumor effects of a nonsteroidal anti-inflammatory drug zaltoprofen on chondrosarcoma via activating peroxisome proliferator-activated receptor gamma and suppressing matrix metalloproteinase-2 expression.

Authors:  Takashi Higuchi; Akihiko Takeuchi; Seiichi Munesue; Norio Yamamoto; Katsuhiro Hayashi; Hiroaki Kimura; Shinji Miwa; Hiroyuki Inatani; Shingo Shimozaki; Takashi Kato; Yu Aoki; Kensaku Abe; Yuta Taniguchi; Hisaki Aiba; Hideki Murakami; Ai Harashima; Yasuhiko Yamamoto; Hiroyuki Tsuchiya
Journal:  Cancer Med       Date:  2018-03-23       Impact factor: 4.452

Review 7.  A Review of Chronic Musculoskeletal Pain: Central and Peripheral Effects of Diclofenac.

Authors:  Fabiola Atzeni; Ignazio Francesco Masala; Piercarlo Sarzi-Puttini
Journal:  Pain Ther       Date:  2018-06-05

8.  Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: a study protocol.

Authors:  Akihiko Takeuchi; Akihiro Nomura; Norio Yamamoto; Katsuhiro Hayashi; Kentaro Igarashi; Susumu Tandai; Akira Kawai; Akihiko Matsumine; Shinji Miwa; Yoshihiro Nishida; Tomoki Nakamura; Ryu Terauchi; Manabu Hoshi; Toshiyuki Kunisada; Makoto Endo; Kenichi Yoshimura; Toshinori Murayama; Hiroyuki Tsuchiya
Journal:  BMC Musculoskelet Disord       Date:  2019-02-09       Impact factor: 2.362

Review 9.  Apoptosis, Autophagy, NETosis, Necroptosis, and Pyroptosis Mediated Programmed Cell Death as Targets for Innovative Therapy in Rheumatoid Arthritis.

Authors:  Jianan Zhao; Ping Jiang; Shicheng Guo; Steven J Schrodi; Dongyi He
Journal:  Front Immunol       Date:  2021-12-24       Impact factor: 7.561

10.  Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts.

Authors:  Natsuko Kusunoki; Ryuta Yamazaki; Hidero Kitasato; Moroe Beppu; Haruhito Aoki; Shinichi Kawai
Journal:  BMC Pharmacol       Date:  2004-02-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.